Tissue inhibitors of metalloproteinases (TIMPs) are a family of secreted proteins that regulate the activation and proteolytic activity of the zinc enzymes known as matrix metalloproteinases (MMPs). There are four known members of the family, TIMP-1, -2, -3 and -4. TIMP-4 is produced by a wide range of tissues, particularly brain, heart, ovary and skeletal muscle (1, 2). Limited studies have shown that TIMP-4 has a tumor suppressive effect against Wilm’s tumor, exhibits negative correlation with glioma maligancy and is found in breast carcinoma cells (3-5). TIMP-4 inhibits MMP-mediated proteolysis by forming a non-covalent binary complex with the MMP active site through its N-terminal domain. In addition, it binds to the hemopexin-like domain of pro-MMP-2 through its C-terminal domain in a manner similar to TIMP-2 (6). However, unlike TIMP-2, TIMP-4 does not promote pro-MMP-2 activation by MT1-MMP (MMP-14) (7). Although TIMP-4 is a potent inhibitor of most MMPs, it is not an effective inhibitor of ADAMs, such as TACE (8, 9).
Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF
R&D Systems | Catalog # 974-TSF
Key Product Details
- R&D Systems Sf 21 (baculovirus)-derived Recombinant Human TIMP-4 (Sf 21-expressed) Protein (974-TSF)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Accession Number
Applications
Product Specifications
Source
Cys30-Pro224
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The IC50 value is approximately 2.5 nM, as measured under the described conditions.
Formulation, Preparation, and Storage
974-TSF
| Formulation | Lyophilized from a 0.2 μm filtered solution in Tris and NaCl. |
| Reconstitution | Reconstitute at 200 μg/mL in sterile, deionized water.
Loading...
|
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Calculators
Background: TIMP-4
References
- Greene, et al. (1996) J. Biol. Chem. 271:30375.
- Leco, et al. (1997) FEBS Lett. 401:213.
- Geliker, et al. (2001) Oncogene 20:4337.
- Groft, et al. (2001) Br. J. Cancer 85:55.
- Hurst, et al. (2001) Biochem. Biophys. Res. Comm. 281:166.
- Bigg, et al. (1997) J. Biol. Chem. 272:15496.
- Hernandez-Barrantes, et al. (2001) Biochem. Biophys. Res. Comm. 281:126.
- Amour, et al. (1998) FEBS Lett. 435:39.
- Liu, et al. (1997) J. Biol. Chem. 272:20479.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional TIMP-4 Products
Product Documents for Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF
For research use only
Related Research Areas
Citations for Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF
Customer Reviews for Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF and earn rewards!
Have you used Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human TIMP-4 (Sf 21-expressed) Protein, CF (974-TSF):
- Assay Buffer: 50 mM Tris, 10 mM CaCl2, 150 mM NaCl, 0.05% (w/v) Brij-35, pH 7.5 (TCNB)
- Recombinant human TIMP-4 (rhTIMP-4) (Catalog # 974-TSF)
- Recombinant Human MMP‑2 (rhMMP‑2) (Catalog # 902-MP)
- 4-Aminophenylmercuric acetate (APMA) (Sigma, Catalog # A-9563), 100 mM stock in DMSO
- Substrate: MCA-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2 (Catalog # ES001), 2 mM stock in DMSO
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute rhMMP-2 to 100 µg/mL with 1 mM APMA in Assay Buffer.
- Incubate at 37 ºC for 1 hour (to activate).
- Prepare a curve of rhTIMP-4 (MW: 22,400 Da) in Assay Buffer. Make serial dilutions of: 5000, 2000, 1000, 500, 300, 200, 150, 100, 20, and 2 nM.
- After activation, dilute 100 µg/mL rhMMP-2 to 12.5 µg/mL in Assay Buffer.
- Mix 16 µL of rhTIMP-4 curve dilutions, 25.6 µL of diluted rhMMP-2, and 118.4 µL of Assay Buffer. Include a control (in duplicate) containing 134.4 µL of Assay Buffer and 25.6 µL of diluted rhMMP-2.
- Incubate reactions for 2 hours at 37 °C.
- After incubation, dilute the mixtures five fold in Assay Buffer.
- Dilute Substrate to 10 µM in Assay Buffer.
- Load 50 µL of the diluted incubated mixtures in a plate, and start the reaction by adding 50 µL of 10 µM Substrate.
- Read at excitation and emission wavelengths of 320 nm and 405 nm (top read), respectively in kinetic mode for 5 minutes.
- Derive the 50% inhibiting concentration (IC50) for rhTIMP-4 by plotting RFU/min (or specific activity) vs. concentration with 4-PL fitting.
- The specific activity for rhMMP-2 at each point may be determined using the following formula (if needed):
|
Specific Activity (pmol/min/µg) = |
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU) |
| amount of enzyme (µg) |
*Adjusted for Substrate Blank
**Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975).
Per Well:
- rhMMP-2: 0.020 µg
- rhTIMP-4: 50, 20, 10, 5, 3, 2, 1.5, 1, 0.2, and 0.02 nM
- Substrate: 5 µM